PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 10, 2022Gastroenterology54 citationsOpen Access

A Systematic Review and Meta-analysis of Dietary Interventions Modulating Gut Microbiota and Cardiometabolic Diseases—Striving for New Standards in Microbiome Studies

View Full Paper
IAIlias AttayeMWMoritz V. WarmbrunnABAureline N.A.F. Boot

Key Result

Dietary interventions targeting the gut microbiota modulated composition, blood pressure, and circulating triglycerides (P = .04), but other cardiometabolic parameters were not affected.

Study Design

Type

Meta-Analysis

Structured PICO

Do dietary interventions targeting the gut microbiota improve clinical outcomes in cardiometabolic diseases?

P
Population
Patients in clinical studies assessing cardiometabolic diseases (CMDs)
I
Intervention
Dietary interventions targeting the gut microbiota (GM)
O
Outcome
Clinical outcomes (including gut microbiota composition, blood pressure, and circulating triglycerides)surrogate

Dietary interventions targeting gut microbiota may modulate blood pressure and circulating triglycerides, though current evidence is limited by high heterogeneity and risk of bias.

Main Result

p-value: p=.04

Limitations

  • High methodological heterogeneity
  • High risk of bias
  • high methodological heterogeneity
  • risk of bias

Abstract

BACKGROUND & AIMS: Cardiometabolic diseases (CMDs) have shared properties and causes. Insulin resistance is a risk factor and characteristic of CMDs and has been suggested to be modulated by plasma metabolites derived from gut microbiota (GM). Because diet is among the most important modulators of GM, we performed a systematic review of the literature to assess whether CMDs can be modulated via dietary interventions targeting the GM. METHODS: A systematic review of the literature for clinical studies was performed on Ovid MEDLINE and Ovid Embase. Studies were assessed for risk of bias and patterns of intervention effects. A meta-analysis with random effects models was used to evaluate the effect of dietary interventions on clinical outcomes. RESULTS: = 59%, P = .04). Other CMD parameters were not affected. CONCLUSIONS: Dietary interventions modulate GM composition, blood pressure, and circulating triglycerides. However, current studies have a high methodological heterogeneity and risk of bias. Well-designed and controlled studies are thus necessary to better understand the complex interaction between diet, microbiome, and CMDs. PROSPERO: CRD42020188405.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Attaye et al. (2022) conducted a meta-analysis in Cardiometabolic diseases. Dietary interventions targeting the gut microbiota was evaluated on Clinical outcomes and cardiometabolic parameters (p=.04). Dietary interventions targeting the gut microbiota modulated composition, blood pressure, and circulating triglycerides (P = .04), but other cardiometabolic parameters were not affected.

synapsesocial.com/papers/6aa228081b85e0eabc07ec69https://doi.org/10.1053/j.gastro.2022.02.011
Ask AI
Helpful
Bookmark
Share
View Full Paper